What is Avalo Therapeutics's shares (diluted)?

Avalo Therapeutics (AVTX) reported shares (diluted) of 20.1M in Q1 2026.

How has Avalo Therapeutics's shares (diluted) changed year-over-year?

Avalo Therapeutics's shares (diluted) increased by 91.2% year-over-year, from 10.5M to 20.1M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Avalo Therapeutics AVTX Shares (Diluted)

Shares (Diluted) at other companies

Eli LillyLLY

895.9M-0.5%

AbbVieABBV

1.8B+0.1%

XencorXNCR

75.2M+2.1%

AbCellera Biologics Inc.ABCL

303.1M+1.8%

AnaptysBio, Inc.ANAB

28.7M-6.4%

Absci CorporationABSI

153M+22.9%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's shares (diluted)?: Avalo Therapeutics (AVTX) reported shares (diluted) of 20.1M in Q1 2026.
How has Avalo Therapeutics's shares (diluted) changed year-over-year?: Avalo Therapeutics's shares (diluted) increased by 91.2% year-over-year, from 10.5M to 20.1M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.